ArticleJournal of thoracic disease2020

The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab.

Taichi Matsubara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.